|
1
|
Benjamin EJ, Virani SS, Callaway CW,
Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling
FN, Deo R, et al: Heart Disease and stroke statistics-2018 update:
A report from the American heart association. Circulation.
137:e67–e492. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Virani SS, Alonso A, Aparicio HJ, Benjamin
EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng
S, Delling FN, et al: Heart disease and stroke statistics-2021
update. Circulation. 143:e254–e743. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Endorsed by the Latin American Society of
Interventional Cardiology; PCI WRITING COMMITTEE, ; Levine GN,
Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers
CE, Ellis SG, Guyton RA, et al: 2015 ACC/AHA/SCAI focused update on
primary percutaneous coronary intervention for patients with
ST-elevation myocardial Infarction: An update of the 2011
ACCF/AHA/SCAI guideline for percutaneous coronary intervention and
the 2013 ACCF/AHA guideline for the management of ST-elevation
myocardial infarction: A report of the American College of
Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines and the Society for Cardiovascular Angiography
and Interventions. Catheter Cardiovasc Interv. 87:1001–1019. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anderson JL, Adams CD, Antman EM, Bridges
CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS,
Levin TN, et al: 2012 ACCF/AHA focused update incorporated into the
ACCF/AHA 2007 guidelines for the management of patients with
unstable angina/non-ST-elevation myocardial infarction: A report of
the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines. J Am Coll Cardiol.
61:e179–347. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Weg K, Prinzen FW and Gorgels AP:
Editor's Choice-Reperfusion cardiac arrhythmias and their relation
to reperfusion-induced cell death. Eur Heart J Acute Cardiovasc
Care. 8:142–152. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vanden Berghe T, Linkermann A,
Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis:
The expanding network of non-apoptotic cell death pathways. Nat Rev
Mol Cell Biol. 15:135–147. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji N, Qi Z, Wang Y, Yang X, Yan Z, Li M,
Ge Q and Zhang J: Pyroptosis: A new regulating mechanism in
cardiovascular disease. J Inflamm Res. 14:2647–2666. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han Y, Qiu H, Pei X, Fan Y, Tian H and
Geng J: Low-dose sinapic acid abates the pyroptosis of macrophages
by downregulation of lncRNA-MALAT1 in rats with diabetic
atherosclerosis. J Cardiovasc Pharmacol. 71:104–112. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ibáñez B, Heusch G, Ovize M and Van de
Werf F: Evolving therapies for myocardial ischemia/reperfusion
injury. J Am Coll Cardiol. 65:1454–1471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toldo S and Abbate A: The NLRP3
inflammasome in acute myocardial infarction. Nat Rev Cardiol.
15:203–214. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van Hout GP, Bosch L, Ellenbroek GH, de
Haan JJ, van Solinge WW, Cooper MA, Arslan F, de Jager SC,
Robertson AA, Pasterkamp G and Hoefer IE: The selective
NLRP3-inflammasome inhibitor MCC950 reduces infarct size and
preserves cardiac function in a pig model of myocardial infarction.
Eur Heart J. 38:828–836. 2017.PubMed/NCBI
|
|
13
|
He WT, Wan H, Hu L, Chen P, Wang X, Huang
Z, Yang ZH, Zhong CQ and Han J: Gasdermin D is an executor of
pyroptosis and required for interleukin-1β secretion. Cell Res.
25:1285–1298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia C, Chen H, Zhang J, Zhou K, Zhuge Y,
Niu C, Qiu J, Rong X, Shi Z, Xiao J, et al: Role of pyroptosis in
cardiovascular diseases. Int Immunopharmacol. 67:311–318. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lei Q, Yi T and Chen C: NF-κB-Gasdermin D
(GSDMD) axis couples oxidative stress and NACHT, LRR and PYD
domains-containing protein 3 (NLRP3) inflammasome-mediated
cardiomyocyte pyroptosis following myocardial infarction. Med Sci
Monit. 24:6044–6052. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han B, Xu J, Shi X, Zheng Z, Shi F, Jiang
F and Han J: DL-3-n-butylphthalide attenuates myocardial
hypertrophy by targeting gasdermin D and inhibiting gasdermin D
mediated inflammation. Front Pharmacol. 12:6881402021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanai H, Negishi H and Taniguchi T: The
IRF family of transcription factors: Inception, impact and
implications in oncogenesis. Oncoimmunology. 1:1376–1386. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamura T, Yanai H, Savitsky D and
Taniguchi T: The IRF family transcription factors in immunity and
oncogenesis. Annu Rev Immunol. 26:535–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heinz S, Haehnel V, Karaghiosoff M,
Schwarzfischer L, Müller M, Krause SW and Rehli M: Species-specific
regulation of Toll-like receptor 3 genes in men and mice. J Biol
Chem. 278:21502–21509. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun L, Jiang Z, Acosta-Rodriguez VA,
Berger M, Du X, Choi JH, Wang J, Wang KW, Kilaru GK, Mohawk JA, et
al: HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription
and for survival during viral infections. J Exp Med. 214:3263–3277.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kayagaki N, Lee BL, Stowe IB, Kornfeld OS,
O'Rourke K, Mirrashidi KM, Haley B, Watanabe C, Roose-Girma M,
Modrusan Z, et al: IRF2 transcriptionally induces GSDMD expression
for pyroptosis. Sci Signal. 12:eaax49172019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bock-Marquette I, Saxena A, White MD,
Dimaio JM and Srivastava D: Thymosin beta4 activates
integrin-linked kinase and promotes cardiac cell migration,
survival and cardiac repair. Nature. 432:466–472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Z, Wang Z, Guan Q, Qiu F, Li Y, Liu
Z, Zhang H, Dong H and Zhang Z: PEDF inhibits the activation of
NLRP3 inflammasome in hypoxia cardiomyocytes through PEDF
receptor/phospholipase A2. Int J Mol Sci. 17:20642016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen A, Chen Z, Xia Y, Lu D, Yang X, Sun
A, Zou Y, Qian J and Ge J: Liraglutide attenuates NLRP3
inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS
pathway in H9c2 cells. Biochem Biophys Res Commun. 499:267–272.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Montojo J, Zuberi K, Rodriguez H, Bader GD
and Morris Q: GeneMANIA: Fast gene network construction and
function prediction for Cytoscape. F1000Res. 3:1532014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bellis A, Di Gioia G, Mauro C, Mancusi C,
Barbato E, Izzo R, Trimarco B and Morisco C: Reducing cardiac
injury during ST-elevation myocardial infarction: A reasoned
approach to a multitarget therapeutic strategy. J Clin Med.
10:29682021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rymer JA, Fonseca E, Bhandary DD, Kumar D,
Khan ND and Wang TY: Difference in medication adherence between
patients prescribed a 30-day versus 90-day supply after acute
myocardial infarction. J Am Heart Assoc. 10:e0162152021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
England RN and Autieri MV:
Anti-inflammatory effects of interleukin-19 in vascular disease.
Int J Inflam. 2012:2535832012.PubMed/NCBI
|
|
32
|
Cookson BT and Brennan MA:
Pro-inflammatory programmed cell death. Trends Microbiol.
9:113–114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nazir S, Gadi I, Al-Dabet MM, Elwakiel A,
Kohli S, Ghosh S, Manoharan J, Ranjan S, Bock F, Braun-Dullaeus RC,
et al: Cytoprotective activated protein C averts Nlrp3
inflammasome-induced ischemia-reperfusion injury via mTORC1
inhibition. Blood. 130:2664–2677. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dolunay A, Senol SP, Temiz-Resitoglu M,
Guden DS, Sari AN, Sahan-Firat S and Tunctan B: Inhibition of NLRP3
inflammasome prevents LPS-induced inflammatory hyperalgesia in
mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS
Isoforms. Inflammation. 40:366–386. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Birnbaum MJ, van Zundert B, Vaughan PS,
Whitmarsh AJ, van Wijnen AJ, Davis RJ, Stein GS and Stein JL:
Phosphorylation of the oncogenic transcription factor interferon
regulatory factor 2 (IRF2) in vitro and in vivo. J Cell Biochem.
66:175–183. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li YR, Wen LQ, Wang Y, Zhou TC, Ma N, Hou
ZH and Jiang ZP: MicroRNA-520c enhances cell proliferation,
migration, and invasion by suppressing IRF2 in gastric cancer. FEBS
Open Bio. 6:1257–1266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yongyu Z, Lewei Y, Jian L and Yuqin S:
[ARTICLE WITHDRAWN] MicroRNA-18a Targets IRF2 and CBX7 to promote
cell proliferation in hepatocellular carcinoma. Oncol Res.
26:1327–1334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liang C, Zhang X, Wang HM, Liu XM, Zhang
XJ, Zheng B, Qian GR and Ma ZL: MicroRNA-18a-5p functions as an
oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis.
8:e27642017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi J, Gao W and Shao F: Pyroptosis:
Gasdermin-mediated programmed necrotic cell death. Trends Biochem
Sci. 42:245–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yuan B, Zhou XM, You ZQ, Xu WD, Fan JM,
Chen SJ, Han YL, Wu Q and Zhang X: Inhibition of AIM2 inflammasome
activation alleviates GSDMD-induced pyroptosis in early brain
injury after subarachnoid haemorrhage. Cell Death Dis. 11:762020.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gao L, Dong X, Gong W, Huang W, Xue J, Zhu
Q, Ma N, Chen W, Fu X, Gao X, et al: Acinar cell NLRP3 inflammasome
and gasdermin D (GSDMD) activation mediates pyroptosis and systemic
inflammation in acute pancreatitis. Br J Pharmacol. 178:3533–3552.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Deten A, Volz HC, Briest W and Zimmer HG:
Cardiac cytokine expression is upregulated in the acute phase after
myocardial infarction. Experimental studies in rats. Cardiovasc
Res. 55:329–340. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Abbate A, Van Tassell BW, Seropian IM,
Toldo S, Robati R, Varma A, Salloum FN, Smithson L and Dinarello
CA: Interleukin-1beta modulation using a genetically engineered
antibody prevents adverse cardiac remodelling following acute
myocardial infarction in the mouse. Eur J Heart Fail. 12:319–322.
2010. View Article : Google Scholar : PubMed/NCBI
|
